RBM4-regulated alternative splicing suppresses tumorigenesis

Area of Science:

• Molecular Biology
• Oncology
• Gene Regulation

Background:

• Aberrant gene splicing is a hallmark of many cancers, contributing to tumor progression.
• RNA-binding proteins play critical roles in post-transcriptional gene regulation, influencing cellular functions.
• The specific role of RNA-binding protein 4 (RBM4) in cancer-associated splicing remains to be fully elucidated.

Purpose of the Study:

• To investigate the function of RBM4 in cancer cell growth and migration.
• To determine whether RBM4 regulates cancer-associated gene splicing.
• To elucidate the molecular mechanisms underlying RBM4's effects on cancer cells.

Main Methods:

• Cell culture models of various cancer types.
• Western blotting and quantitative real-time PCR to assess protein and gene expression.
• Splicing-sensitive assays to analyze alternative splicing events.
• Migration and proliferation assays.

Main Results:

• RBM4 expression was found to be inversely correlated with tumor aggressiveness in several cancer types.
• Knockdown of RBM4 promoted cancer cell proliferation and migration.
• RBM4 was demonstrated to regulate the splicing of key cancer-associated genes, including those involved in cell cycle progression and metastasis.
• Overexpression of RBM4 inhibited cancer cell growth and migration.

Conclusions:

• RNA-binding protein 4 (RBM4) acts as a tumor suppressor by inhibiting cancer cell growth and migration.
• RBM4 exerts its tumor-suppressive effects through the regulation of cancer-associated gene splicing.
• Targeting RBM4 or its downstream splicing targets may represent a novel therapeutic strategy for cancer treatment.